WIM
VRTX icon

Westside Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Westside Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.6K Hold
179
– – 0.01% 459
2025
Q4 		$80.9K Buy
179
+3
+2% +$1.29K 0.01% 432
2025
Q3 		$71.1K Buy
176
+73
+71% +$30.5K 0.01% 461
2025
Q2 		$46.6K Buy
103
+73
+243% +$33.6K 0.01% 471
2025
Q1 		$14.5K Buy
30
+17
+131% +$7.92K ﹤0.01% 625
2024
Q4 		$5.24K Hold
13
– – ﹤0.01% 768
2024
Q3 		$6.58K Hold
13
– – ﹤0.01% 743
2024
Q2 		$6.09K Buy
+13
New +$5.64K ﹤0.01% 730
2020
Q3 		– Sell
-10
Closed -$2 – 701
2020
Q2 		$2 Buy
+10
New +$2.71K ﹤0.01% 604

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Westside Investment Management's VRTX Position: Q1 2026 in Review

Westside Investment Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 179 shares worth $78.6K. The position accounts for 0.01% of the portfolio, ranked #459.

Westside Investment Management first reported a position in VRTX in Q2 2020 and has held it in 9 quarters since. The position peaked at $80.9K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Westside Investment Management held 179 shares of Vertex Pharmaceuticals worth $78.6K as of Q1 2026.
  • Westside Investment Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.01% of Westside Investment Management's portfolio in Q1 2026, its #459 holding.
  • Westside Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 9 quarters since.
  • Westside Investment Management's Vertex Pharmaceuticals position peaked at $80.9K in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Westside Investment Management's 13F filing for Q1 2026, filed 4 May 2026.